BLAST Study (H-36486)
Description
Content
Pilot Study of Celecoxib Combined With Gemcitabine and Cisplatin for Neoadjuvant Treatment of Localized, Muscle-Invasive Bladder Cancer
The purpose of this study is to compare patient tumor tissue before and after treatment with standard chemotherapy (gemcitabine+cisplatin) plus celecoxib.
For study details see Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer (BLAST).
Contact
Phone 1: 713–798–1354
IRB: H-36486
Status:
Active
Created:
